Economic burden of hematologic adverse events (AEs) associated with metastatic colorectal cancer (mCRC) treatment in the United States (US).

e15008Background: Hematologic (HEM) AEs are common during treatment (tx) for mCRC and have been associated with a significant economic burden. This study assessed the incremental costs of HEM AEs v...